Ciclesonide Inhaler for Post-Acute COVID-19 Syndrome: Promisingclinical Evidence
Pharmacy Practice This article, using data from Oman, argues that despite demographic limitations, early use of ciclesonide in COVID-19 patients has shown promising results in research. Journal Article
Read More